# OnCo record bicycle-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bicycle-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bicycle-therapeutics" ;
  schema:name "Bicycle Therapeutics"@en ;
  schema:description "Inventor of bicyclic peptide drug conjugates; its lead Nectin-4 conjugate was deprioritised in 2026 after regulatory feedback."@en ;
  schema:url <https://onco.cc/companies/bicycle-therapeutics/>, <https://www.bicycletherapeutics.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.bicycletherapeutics.com> ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> ;
  onco:drugs <https://onco.cc/drugs/zelenectide-pevedotin/> ;
  onco:trials <https://onco.cc/trials/nct07450859/>, <https://onco.cc/trials/nct05163041/>, <https://onco.cc/trials/nct04561362/>, <https://onco.cc/trials/nct06225596/>, <https://onco.cc/trials/nct06840483/>, <https://onco.cc/trials/nct04180371/>, <https://onco.cc/trials/nct06933329/> .